OverviewChartNewsTraderScreen

UniCredit Knock-Out BRM/  DE000HD0WHK5  /

EUWAX
2024-05-22  4:59:29 PM Chg.+0.020 Bid6:09:55 PM Ask6:09:55 PM Underlying Strike price Expiration date Option type
0.340EUR +6.25% 0.330
Bid Size: 200,000		 0.340
Ask Size: 200,000		 BRISTOL-MYERS SQUIBB... 39.1283 - 2078-12-31 Call
GlobeNewswire 1:30 PM Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 05-15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 05-14 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...
GlobeNewswire 05-14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 05-13 Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Immunocore reports first quarter financial results and provides a business update
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-02 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...
GlobeNewswire 05-01 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 04-30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
GlobeNewswire 04-30 CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical D...
GlobeNewswire 04-25 International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on A...
GlobeNewswire 04-25 Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract ...
GlobeNewswire 04-25 Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire 04-22 ArriVent Appoints Kristine Peterson to its Board of Directors
GlobeNewswire 04-08 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Sq...
GlobeNewswire 04-08 Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
GlobeNewswire 04-08 TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H.,...
GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 04-05 Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies D...
GlobeNewswire 04-03 Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the...
GlobeNewswire 04-03 CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engag...